4.7 Article

RGS16 regulated by let-7c-5p promotes glioma progression by activating PI3K-AKT pathway

Journal

FRONTIERS OF MEDICINE
Volume 17, Issue 1, Pages 143-155

Publisher

SPRINGER
DOI: 10.1007/s11684-022-0929-y

Keywords

RGS16; let-7c-5p; glioma; proliferation; migration

Ask authors/readers for more resources

It has been confirmed that RGS16 is upregulated in glioma tissues and its high expression is associated with poor survival. Deleting RGS16 significantly suppresses glioma cell proliferation and migration. Moreover, RGS16 has been validated as a direct target gene of miR let-7c-5p. Therefore, the inhibition of RGS16 may promote glioma progression and could potentially serve as a prognostic biomarker and therapeutic target for glioma.
Gliomas are the most common central nervous system tumours; they are highly aggressive and have a poor prognosis. RGS16 belongs to the regulator of G-protein signalling (RGS) protein family, which plays an important role in promoting various cancers, such as breast cancer, pancreatic cancer, and colorectal cancer. Moreover, previous studies confirmed that let-7c-5p, a well-known microRNA, can act as a tumour suppressor to regulate the progression of various tumours by inhibiting the expression of its target genes. However, whether RGS16 can promote the progression of glioma and whether it is regulated by miR let-7c-5p are still unknown. Here, we confirmed that RGS16 is upregulated in glioma tissues and that high expression of RGS16 is associated with poor survival. Ectopic deletion of RGS16 significantly suppressed glioma cell proliferation and migration both in vitro and in vivo. Moreover, RGS16 was validated as a direct target gene of miR let-7c-5p. The overexpression of miR let-7c-5p obviously downregulated the expression of RGS16, and knocking down miR let-7c-5p had the opposite effect. Thus, we suggest that the suppression of RGS16 by miR let-7c-5p can promote glioma progression and may serve as a potential prognostic biomarker and therapeutic target in glioma.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells

Zihang Chen, Huizhi Wang, Zongpu Zhang, Jianye Xu, Yanhua Qi, Hao Xue, Zijie Gao, Rongrong Zhao, Shaobo Wang, Shouji Zhang, Wei Qiu, Xing Guo, Gang Li

Summary: Surface expression of glucose-regulated protein 78 (csGRP78) was found to be preferentially expressed in MES GSCs, and targeting csGRP78 effectively suppressed self-renewal and radioresistance of MES GSCs both in vitro and in vivo by downregulating STAT3, NF-kappa B, and C/EBP beta pathways, potentially through regulation of downstream molecule BACE2. These findings suggest that blocking csGRP78 with a high-specificity antibody could be a promising therapeutic strategy for glioblastoma treatment.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Medicine, Research & Experimental

Exosomes derived from hypoxic glioma deliver miR-1246 and miR-10b-5p to normoxic glioma cells to promote migration and invasion

Mingyu Qian, Zihang Chen, Xiaofan Guo, Shaobo Wang, Zongpu Zhang, Wei Qiu, Yanhua Qi, Shouji Zhang, Jianye Xu, Rongrong Zhao, Hao Xue, Gang Li

Summary: This study reveals that hypoxic glioma exosomes promote normoxic glioma migration and invasion by delivering miR-1246 and miR-10b-5p. These microRNAs significantly induce glioma cell motility both in vitro and in vivo by directly targeting different genes. Targeting miR-1246 and miR-10b-5p may impair the motility of gliomas, suggesting a potential for novel anti-tumor therapy development.

LABORATORY INVESTIGATION (2021)

Article Biochemistry & Molecular Biology

EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3

Ziwen Pan, Rongrong Zhao, Boyan Li, Yanhua Qi, Wei Qiu, Qindong Guo, Shouji Zhang, Shulin Zhao, Hao Xu, Ming Li, Zijie Gao, Yang Fan, Jianye Xu, Huizhi Wang, Shaobo Wang, Jiawei Qiu, Qingtong Wang, Xing Guo, Lin Deng, Ping Zhang, Hao Xue, Gang Li

Summary: This study reveals the significant role of circNEIL3 in promoting gliomagenesis and malignant progression, as well as in driving macrophage infiltration into the tumour microenvironment. CircNEIL3 may serve as a potential prognostic biomarker and therapeutic target for gliomas.

MOLECULAR CANCER (2022)

Article Immunology

The Non-N6-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma

Jianye Xu, Zijie Gao, Kaining Liu, Yang Fan, Zongpu Zhang, Hao Xue, Xing Guo, Ping Zhang, Lin Deng, Shaobo Wang, Huizhi Wang, Qingtong Wang, Rongrong Zhao, Gang Li

Summary: This study identified three distinct non-m(6)A RNA modification patterns associated with diverse biological pathways and clinical characteristics. Patients with a high RM score exhibited poor prognosis, enhanced immune infiltration, and MES subtype. Furthermore, the high RM score group had lower tumor mutation burden and weaker response to immunotherapy, but may benefit more from drugs targeting the EGFR and WNT signaling pathways.

FRONTIERS IN IMMUNOLOGY (2022)

Article Cell Biology

The dual role of glioma exosomal microRNAs: glioma eliminates tumor suppressor miR-1298-5p via exosomes to promote immunosuppressive effects of MDSCs

Yanhua Qi, Chuandi Jin, Wei Qiu, Rongrong Zhao, Shaobo Wang, Boyan Li, Zongpu Zhang, Qindong Guo, Shouji Zhang, Zijie Gao, Shulin Zhao, Ziwen Pan, Yang Fan, Zihang Chen, Huizhi Wang, Jianye Xu, Lin Deng, Shilei Ni, Jian Wang, Hao Xue, Fuzhong Xue, Gang Li

Summary: Clear evidence shows that tumors can use exosomes to secrete microRNAs for modulating the tumor microenvironment. In this study, miRNAs were found to be divided into exosome-enriched miRNAs and intracellular-retained miRNAs, with exosome-enriched miRNAs playing a dual role. Specifically, miR-1298-5p was enriched in CSF exosomes and demonstrated to suppress glioma progression while promoting the immunosuppressive effects of myeloid-derived suppressor cells (MDSCs). Mechanically, miR-1298-5p targeted SETD7 and MSH2 in glioma cells and MDSCs, respectively. These findings provide insights into the selective sorting of miRNAs into exosomes and their role in modulating tumor immunity in glioma.

CELL DEATH & DISEASE (2022)

Article Medicine, Research & Experimental

SPI1-induced downregulation of FTO promotes GBM progression by regulating pri-miR-10a processing in an m6A-dependent manner

Shouji Zhang, Shulin Zhao, Yanhua Qi, Boyan Li, Huizhi Wang, Ziwen Pan, Hao Xue, Chuandi Jin, Wei Qiu, Zihang Chen, Qindong Guo, Yang Fan, Jianye Xu, Zijie Gao, Shaobo Wang, Xing Guo, Lin Deng, Shilei Ni, Fuzhong Xue, Jian Wang, Rongrong Zhao, Gang Li

Summary: This study explores the function of FTO, an m(6)A demethylase, in glioblastoma (GBM). The findings suggest that FTO downregulation is associated with higher glioma grades and poorer clinical outcomes. FTO inhibits GBM cell growth and invasion by regulating the m(6)A modification of pri-miR-10a. Additionally, the transcriptional activity of FTO is inhibited by SPI1, and treatment with the SPI1 inhibitor can restore FTO expression and decrease GBM tumor burden.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

Article Immunology

A Comprehensive Analysis of METTL1 to Immunity and Stemness in Pan-Cancer

Zijie Gao, Jianye Xu, Zongpu Zhang, Yang Fan, Hao Xue, Xing Guo, Lin Deng, Shaobo Wang, Rongrong Zhao, Ping Zhang, Gang Li

Summary: This study reveals the correlation of METTL1 with tumor immune infiltration and stemness in pan-cancer, highlighting the significance of METTL1 in cancer progression and guiding more effective and generalized therapy strategies.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition

Zijie Gao, Jianye Xu, Yang Fan, Yanhua Qi, Shaobo Wang, Shulin Zhao, Xing Guo, Hao Xue, Lin Deng, Rongrong Zhao, Chong Sun, Ping Zhang, Gang Li

Summary: This study identified a lncRNA, PDIA3P1, that is upregulated in TMZ-resistant GBM cell lines. Overexpression of PDIA3P1 promotes TMZ resistance, while knockdown of PDIA3P1 restores TMZ sensitivity. PDIA3P1 promotes PMT in GBM cells by stabilizing C/EBP beta, reducing their sensitivity to TMZ treatment.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Immunology

Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma

Yang Fan, Zijie Gao, Jianye Xu, Huizhi Wang, Qindong Guo, Hao Xue, Rongrong Zhao, Xing Guo, Gang Li

Summary: This study reveals the role of small nucleolar RNA host genes (SNHGs) in glioblastoma (GBM) subtypes, tumor microenvironment (TME) infiltration, and stemness characteristics. By generating the SNHGscore model, it was found that the high SNHGscore group had a poor prognosis, the mesenchymal (MES) subtype, infiltration of suppressive immune cells, and a differentiated phenotype. Furthermore, high SNHGscore was associated with a weaker response to anti-PD-1/L1 immunotherapy and tumor cells with high SNHG scores were more sensitive to drugs targeting the EGFR and ERK-MAPK signaling pathways. Additionally, the universality of SNHG interaction patterns was verified in multiple cancers, highlighting the potential clinical utility for cancer therapy.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells

Zijie Gao, Jianye Xu, Yang Fan, Zongpu Zhang, Huizhi Wang, Mingyu Qian, Ping Zhang, Lin Deng, Jie Shen, Hao Xue, Rongrong Zhao, Teng Zhou, Xing Guo, Gang Li

Summary: ARPC1B is upregulated in MES-GBM/GSCs and correlated with poor prognosis. Knockdown of ARPC1B reduces radiotherapy resistance in GSCs. ARPC1B interacts with IFI16 and HuR to maintain protein stability and activates NF-kappa B and STAT3 pathways, promoting MES phenotype maintenance and radiotherapy resistance. Furthermore, AZD6738, identified based on ARPC1B expression, exhibits excellent anti-GSC activity in combination with radiotherapy.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

Hypoxia-induced circADAMTS6 in a TDP43-dependent manner accelerates glioblastoma progression via ANXA2/ NF-κB pathway

Shulin Zhao, Boyan Li, Rongrong Zhao, Ziwen Pan, Shouji Zhang, Wei Qiu, Qindong Guo, Yanhua Qi, Zijie Gao, Yang Fan, Hao Xu, Ming Li, Jian Zhang, Huizhi Wang, Jianye Xu, Shaobo Wang, Qingtong Wang, Jiawei Qiu, Lin Deng, Xing Guo, Ping Zhang, Hao Xue, Gang Li

Summary: In this study, a previously unreported circRNA named circADAMTS6 was found to be specifically upregulated in the hypoxic microenvironment of glioblastoma and was closely related to poor prognosis. CircADAMTS6 was shown to promote malignant progression of glioblastoma by enhancing cell proliferation, inhibiting apoptosis, and regulating the NF-kappa B pathway. Targeting circADAMTS6 could be a novel therapeutic strategy for glioblastoma.

ONCOGENE (2023)

Article Cell Biology

Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia

Qindong Guo, Yang Fan, Qingtong Wang, Boyan Li, Wei Qiu, Yanhua Qi, Ziwen Pan, Shouji Zhang, Shulin Zhao, Kehui Yang, Hao Xu, Ming Li, Zijie Gao, Jianye Xu, Huizhi Wang, Shaobo Wang, Qilin Tang, Jiawei Qiu, Xing Guo, Lin Deng, Ping Zhang, Rongrong Zhao, Hao Xue, Chengwei Wang, Gang Li

Summary: This study found that glioma cells can eliminate suppressor miR-204-3p to accelerate angiogenesis under hypoxia by upregulating SUMOylation. hnRNP A2/B1 can accelerate exosome sorting of miR-204-3p by binding a specific sequence. The SUMOylation inhibitor TAK-981 could be a potential drug for glioma by inhibiting the exosome sorting process of miR-204-3p to inhibit tumor growth and angiogenesis.

CELL DEATH & DISEASE (2023)

Article Immunology

Inhibition of neutrophil extracellular trap formation ameliorates neuroinflammation and neuronal apoptosis via STING-dependent IRE1α/ASK1/JNK signaling pathway in mice with traumatic brain injury

Guihong Shi, Liang Liu, Yiyao Cao, Guangshuo Ma, Yanlin Zhu, Jianye Xu, Xu Zhang, Tuo Li, Liang Mi, Haoran Jia, Yanfeng Zhang, Xilei Liu, Yuan Zhou, Shenghui Li, Guili Yang, Xiao Liu, Fanglian Chen, Baolong Wang, Quanjun Deng, Shu Zhang, Jianning Zhang

Summary: This study found that inhibition of NETs can alleviate neuroinflammation, neuronal apoptosis, and neurological deficits after traumatic brain injury (TBI). This effect is mediated through the STING-dependent IRE1 alpha/ASK1/JNK signaling pathway. The findings suggest that targeting NETs may be a promising therapeutic approach for the early management of TBI.

JOURNAL OF NEUROINFLAMMATION (2023)

Article Medicine, Research & Experimental

SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages

Yang Fan, Zijie Gao, Jianye Xu, Huizhi Wang, Qindong Guo, Boyan Li, Ming Li, Hao Xu, Yanhua Qi, Shulin Zhao, Wei Qiu, Ziwen Pan, Qingtong Wang, Hao Xue, Rongrong Zhao, Xing Guo, Gang Li

Summary: This study found that targeting SPI1 to block transcription of the MIR222HG cluster helps reduce radioresistance and combat the immunosuppressive microenvironment in GBM. PLX-4720 is a potential GBM drug and radiosensitizer.

THERANOSTICS (2023)

No Data Available